Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults. I Antibody concentrations, avidity and functional activity
<p>Abstract</p> <p><it>Streptococcus pneumoniae </it>is a serious worldwide pathogen and the focus of numerous vaccine development projects. Currently the most widely accepted surrogate marker for evaluating the efficacy of a given vaccine is to utilize ELISA. Measureme...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2005-06-01
|
| Series: | Immunity & Ageing |
| Online Access: | http://www.immunityageing.com/content/2/1/10 |
| _version_ | 1818749973488992256 |
|---|---|
| author | Carlone George M Romero-Steiner Sandra Khuder Sadik Shriner Anne K Smithson S Louise Kolibab Kris Westerink MA Julie |
| author_facet | Carlone George M Romero-Steiner Sandra Khuder Sadik Shriner Anne K Smithson S Louise Kolibab Kris Westerink MA Julie |
| author_sort | Carlone George M |
| collection | DOAJ |
| description | <p>Abstract</p> <p><it>Streptococcus pneumoniae </it>is a serious worldwide pathogen and the focus of numerous vaccine development projects. Currently the most widely accepted surrogate marker for evaluating the efficacy of a given vaccine is to utilize ELISA. Measurement of antibody concentration by ELISA without reduction in cross-reactive antibodies causes an overestimation of antibody concentration and therefore protection, this is most notable in the aged, an at risk group for this infection. We compared the immune response to the pneumococcal polysaccharides (PPS) 4 and 14 of 20 young to 20 elderly adults. Pre-and post-vaccination IgG antibody concentrations and antibody avidity against PPS4 and PPS14 were measured using two different enzyme-linked immunosorbant assay (ELISA) absorption protocols. All sera were pre-absorbed with either cell-wall polysaccharide (CPS), or CPS and serotype 22F polysaccharide.</p> <p>Pre- and post-vaccination IgG antibody concentrations for serotype 4, but not 14, were significantly lowered with the additional absorption with serotype 22F polysaccharide in both age groups. Young and elderly demonstrated a significant increase from pre- to post-immunization antibody concentration, using either absorption method; and opsonophagocytic antibody titers in response to both PPS4 and PPS14. The correlation coefficients between ELISA and opsonophagocytic assays were improved by additional absorption with serotype 22F in response to serotype 4, but not serotype 14 in all age groups. Opsonophagocytic antibody titers in a sub-group of elderly (>77 years of age) were significantly lower than the opsonophagocytic antibody concentrations in young adults.</p> <p>These results suggest the importance of eliminating cross-reactive antibodies from ELISA measurements by absorption of serum and an age-related impairment in the antibody response to pneumococcal polysaccharides.</p> |
| first_indexed | 2024-12-18T04:12:17Z |
| format | Article |
| id | doaj.art-90bb53e4c69b42259a19324d64a3ce52 |
| institution | Directory Open Access Journal |
| issn | 1742-4933 |
| language | English |
| last_indexed | 2024-12-18T04:12:17Z |
| publishDate | 2005-06-01 |
| publisher | BMC |
| record_format | Article |
| series | Immunity & Ageing |
| spelling | doaj.art-90bb53e4c69b42259a19324d64a3ce522022-12-21T21:21:26ZengBMCImmunity & Ageing1742-49332005-06-01211010.1186/1742-4933-2-10Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults. I Antibody concentrations, avidity and functional activityCarlone George MRomero-Steiner SandraKhuder SadikShriner Anne KSmithson S LouiseKolibab KrisWesterink MA Julie<p>Abstract</p> <p><it>Streptococcus pneumoniae </it>is a serious worldwide pathogen and the focus of numerous vaccine development projects. Currently the most widely accepted surrogate marker for evaluating the efficacy of a given vaccine is to utilize ELISA. Measurement of antibody concentration by ELISA without reduction in cross-reactive antibodies causes an overestimation of antibody concentration and therefore protection, this is most notable in the aged, an at risk group for this infection. We compared the immune response to the pneumococcal polysaccharides (PPS) 4 and 14 of 20 young to 20 elderly adults. Pre-and post-vaccination IgG antibody concentrations and antibody avidity against PPS4 and PPS14 were measured using two different enzyme-linked immunosorbant assay (ELISA) absorption protocols. All sera were pre-absorbed with either cell-wall polysaccharide (CPS), or CPS and serotype 22F polysaccharide.</p> <p>Pre- and post-vaccination IgG antibody concentrations for serotype 4, but not 14, were significantly lowered with the additional absorption with serotype 22F polysaccharide in both age groups. Young and elderly demonstrated a significant increase from pre- to post-immunization antibody concentration, using either absorption method; and opsonophagocytic antibody titers in response to both PPS4 and PPS14. The correlation coefficients between ELISA and opsonophagocytic assays were improved by additional absorption with serotype 22F in response to serotype 4, but not serotype 14 in all age groups. Opsonophagocytic antibody titers in a sub-group of elderly (>77 years of age) were significantly lower than the opsonophagocytic antibody concentrations in young adults.</p> <p>These results suggest the importance of eliminating cross-reactive antibodies from ELISA measurements by absorption of serum and an age-related impairment in the antibody response to pneumococcal polysaccharides.</p>http://www.immunityageing.com/content/2/1/10 |
| spellingShingle | Carlone George M Romero-Steiner Sandra Khuder Sadik Shriner Anne K Smithson S Louise Kolibab Kris Westerink MA Julie Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults. I Antibody concentrations, avidity and functional activity Immunity & Ageing |
| title | Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults. I Antibody concentrations, avidity and functional activity |
| title_full | Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults. I Antibody concentrations, avidity and functional activity |
| title_fullStr | Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults. I Antibody concentrations, avidity and functional activity |
| title_full_unstemmed | Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults. I Antibody concentrations, avidity and functional activity |
| title_short | Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults. I Antibody concentrations, avidity and functional activity |
| title_sort | immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults i antibody concentrations avidity and functional activity |
| url | http://www.immunityageing.com/content/2/1/10 |
| work_keys_str_mv | AT carlonegeorgem immuneresponsetopneumococcalpolysaccharides4and14inelderlyandyoungadultsiantibodyconcentrationsavidityandfunctionalactivity AT romerosteinersandra immuneresponsetopneumococcalpolysaccharides4and14inelderlyandyoungadultsiantibodyconcentrationsavidityandfunctionalactivity AT khudersadik immuneresponsetopneumococcalpolysaccharides4and14inelderlyandyoungadultsiantibodyconcentrationsavidityandfunctionalactivity AT shrinerannek immuneresponsetopneumococcalpolysaccharides4and14inelderlyandyoungadultsiantibodyconcentrationsavidityandfunctionalactivity AT smithsonslouise immuneresponsetopneumococcalpolysaccharides4and14inelderlyandyoungadultsiantibodyconcentrationsavidityandfunctionalactivity AT kolibabkris immuneresponsetopneumococcalpolysaccharides4and14inelderlyandyoungadultsiantibodyconcentrationsavidityandfunctionalactivity AT westerinkmajulie immuneresponsetopneumococcalpolysaccharides4and14inelderlyandyoungadultsiantibodyconcentrationsavidityandfunctionalactivity |